Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants

Tarun Saluja; Sonali Palkar; Puneet Misra; Madhu Gupta; Potula Venugopal; Ashwani Kumar Sood; Ravi Mandyam Dhati; Avinash Shetty; Sangappa Malappa Dhaded; Sharad Agarkhedkar; Amlan Choudhury; Ramesh Kumar; Sundaram Balasubramanian; Sudhir Babji; Lopa Adhikary; Martin Dupuy; Sangeet Mohan Chadha; Forum Desai; Darshna Kukian; Badri Narayan Patnaik; Mandeep Singh Dhingra

doi:10.1016/j.vaccine.2017.05.019

Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants

Vaccine ◽

10.1016/j.vaccine.2017.05.019 ◽

2017 ◽

Vol 35 (28) ◽

pp. 3575-3581 ◽

Cited By ~ 3

Author(s):

Tarun Saluja ◽

Sonali Palkar ◽

Puneet Misra ◽

Madhu Gupta ◽

Potula Venugopal ◽

...

Keyword(s):

Phase Iii ◽

Rotavirus Vaccine ◽

Randomized Controlled ◽

Phase Iii Study

Download Full-text

Randomized controlled phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer – AGO DESKTOP III/ENGOT ov20

10.1055/s-0038-1671029 ◽

2018 ◽

Author(s):

P Harter ◽

J Sehouli ◽

W Meier ◽

A Reuss ◽

P Hillemanns ◽

...

Keyword(s):

Ovarian Cancer ◽

Cytoreductive Surgery ◽

Recurrent Ovarian Cancer ◽

Phase Iii ◽

Randomized Controlled ◽

Secondary Cytoreductive Surgery ◽

Phase Iii Study ◽

The Impact

Download Full-text

A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients

Drugs ◽

10.1007/s40265-021-01547-5 ◽

2021 ◽

Author(s):

Anil Gulati ◽

Rajat Choudhuri ◽

Ajay Gupta ◽

Saurabh Singh ◽

S. K. Noushad Ali ◽

...

Keyword(s):

Hypovolemic Shock ◽

Phase Iii ◽

Randomized Controlled ◽

Phase Iii Study

Download Full-text

High-protein intake and early exercise in adult intensive care patients: a randomized controlled phase III study to evaluate the impact on functional outcomes

Clinical Nutrition ESPEN ◽

10.1016/j.clnesp.2021.09.289 ◽

2021 ◽

Vol 46 ◽

pp. S644

Author(s):

J. R. Araujo De Azevedo ◽

H. Lima ◽

P. Frota ◽

I. Nogueira ◽

S. Souza ◽

...

Keyword(s):

Intensive Care ◽

Functional Outcomes ◽

Protein Intake ◽

Phase Iii ◽

High Protein Intake ◽

Early Exercise ◽

Intensive Care Patients ◽

Randomized Controlled ◽

Phase Iii Study ◽

The Impact

Download Full-text

Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial

Contemporary Clinical Trials Communications ◽

10.1016/j.conctc.2020.100536 ◽

2020 ◽

Vol 17 ◽

pp. 100536 ◽

Cited By ~ 5

Author(s):

Christian Pfister ◽

Valentin Harter ◽

Yves Allory ◽

François Radvanyi ◽

Stéphane Culine ◽

...

Keyword(s):

Cell Cancer ◽

Locally Advanced ◽

Transitional Cell ◽

Phase Iii ◽

Randomized Controlled ◽

Cancer Of The Bladder ◽

Transitional Cell Cancer ◽

Phase Iii Study ◽

Dose Dense ◽

Gemcitabine And Cisplatin

Download Full-text

Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial

Trials ◽

10.1186/1745-6215-15-469 ◽

2014 ◽

Vol 15 (1) ◽

Cited By ~ 18

Author(s):

Barbara Burtness ◽

Jean P Bourhis ◽

Jan B Vermorken ◽

Kevin J Harrington ◽

Ezra EW Cohen

Keyword(s):

Randomized Controlled Trial ◽

Head And Neck Cancer ◽

High Risk ◽

Adjuvant Therapy ◽

Controlled Trial ◽

Phase Iii ◽

Double Blind ◽

Randomized Controlled ◽

Phase Iii Study ◽

Head Neck

Download Full-text

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

The Lancet ◽

10.1016/s0140-6736(08)60524-3 ◽

2008 ◽

Vol 371 (9619) ◽

pp. 1181-1189 ◽

Cited By ~ 272

Author(s):

Alexandre C Linhares ◽

F Raúl Velázquez ◽

Irene Pérez-Schael ◽

Xavier Sáez-Llorens ◽

Hector Abate ◽

...

Keyword(s):

Latin American ◽

Phase Iii ◽

Rotavirus Vaccine ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Rotavirus Gastroenteritis ◽

Human Rotavirus ◽

Phase Iii Study

Download Full-text

Multicenter randomized controlled phase III study of nivolumab alone or in combination with ipilimumab as immunotherapy vs standard follow-up in surgically resectable HNSCC after adjuvant therapy

10.1055/s-0040-1710984 ◽

2020 ◽

Author(s):

N Möckelmann ◽

M Binder ◽

CS. Betz ◽

Chia-Jung Busch

Keyword(s):

Adjuvant Therapy ◽

Phase Iii ◽

Randomized Controlled ◽

Phase Iii Study

Download Full-text

Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study

Lung Cancer ◽

10.1016/j.lungcan.2020.09.003 ◽

2020 ◽

Vol 149 ◽

pp. 46-52

Author(s):

Jonathan W. Goldman ◽

Marina Chiara Garassino ◽

Yuanbin Chen ◽

Mustafa Özgüroğlu ◽

Mikhail Dvorkin ◽

...

Keyword(s):

Patient Reported Outcomes ◽

Phase Iii ◽

Small Cell Lung ◽

First Line ◽

Open Label ◽

Randomized Controlled ◽

Patient Reported ◽

Open Label Phase ◽

Phase Iii Study ◽

Extensive Stage

Download Full-text

CoaGlio IV Trial: Randomized, controlled, triple-blind, multinational phase III study of adjuvant prophylactic anticoagulation in patients with glioblastoma WHO IV.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps2079 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS2079-TPS2079

Author(s):

Susanne Antje Kuhn ◽

Christine Marosi ◽

Ingrid Pabinger ◽

Lars Bullinger ◽

Roland Goldbrunner ◽

...

Keyword(s):

Phase Iii ◽

Randomized Controlled ◽

Phase Iii Study ◽

Prophylactic Anticoagulation

Download Full-text

Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study

Health and Quality of Life Outcomes ◽

10.1186/1477-7525-6-75 ◽

2008 ◽

Vol 6 (1) ◽

pp. 75 ◽

Cited By ~ 29

Author(s):

Dennis A Revicki ◽

Alan Menter ◽

Steven Feldman ◽

Miriam Kimel ◽

Neesha Harnam ◽

...

Keyword(s):

Quality Of Life ◽

United States ◽

The United States ◽

Phase Iii ◽

Health Related Quality ◽

Randomized Controlled ◽

Related Quality ◽

Health Related ◽

Phase Iii Study

Download Full-text